Resumo
Diferenciales
Común
- Adenomas adrenais não secretores
Infrecuente
- Síndrome de Cushing
- Feocromocitoma
- Hiperaldosteronismo primário
- Cistos adrenais
- Mielolipomas adrenais
- Hemangiomas adrenais
- Ganglioneuroma adrenal
- Lesões adrenais granulomatosas infiltrantes
- Carcinoma adrenocortical
- Metástases adrenais
- Melanoma maligno de adrenal
Colaboradores
Autores
Benjamin Viglianti, MD, PhD
Associate Professor
Division of Nuclear Medicine
Department of Radiology
University of Michigan
Ann Arbor
MI
Divulgaciones
BV declares that he has no competing interests.
Mitchel Muhleman, MD
Assistant Professor
Division of Nuclear Medicine
Department of Radiology
University of Michigan
Ann Arbor
MI
Divulgaciones
MM declares that he has no competing interests.
Daniel Wale, DO
Associate Professor
Division of Nuclear Medicine
Department of Radiology
University of Michigan
Ann Arbor
MI
Divulgaciones
DW declares that he has no competing interests.
Ka Kit Wong, MBBS
Associate Professor
Division of Nuclear Medicine
Department of Radiology
University of Michigan
Ann Arbor
MI
Divulgaciones
KKW declares that he has no competing interests.
Agradecimientos
Dr Benjamin Viglianti, Dr Mitchel Muhleman, Dr Daniel Wale, and Dr Ka Kit Wong would like to gratefully acknowledge Dr Milton D. Gross and Dr Anca M. Avram, the previous contributors to this topic.
Divulgaciones
MDG is an author of references cited in this topic. AMA declares that he has no competing interests.
Revisores por pares
Shehzad Basaria, MD
Assistant Professor
Johns Hopkins University School of Medicine
Baltimore
MD
Divulgaciones
SB declares that he has no competing interests.
Lawrence S. Kirschner, MD, PhD
Associate Professor of Medicine
Ohio State University
Columbus
OH
Divulgaciones
LSK declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referencias
Artículos principales
Grumbach MM, Biller BM, Braunstein GD, et al. Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med. 2003 Mar 4;138(5):424-9.Texto completo Resumen
Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med. 2007;356:601-10. Resumen
Fassnacht M, Tsagarakis S, Terzolo M, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023 Jul 20;189(1):G1-42.Full text Abstract
Zeiger MA, Thompson GB, Duh QY, et al. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract. 2009 Jul-Aug;15(suppl 1):1-20.Full text Abstract
Expert Panel on Urological Imaging., Mody RN, Remer EM, et al. ACR Appropriateness Criteria® Adrenal Mass Evaluation: 2021 Update. J Am Coll Radiol. 2021 Nov;18(11s):S251-S267.Full text Abstract
Reference articles
A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
Guidelines
- Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors
- ACR Appropriateness Criteria: adrenal mass evaluation
More Guidelines
Log in or subscribe to access all of BMJ Best Practice
Use of this content is subject to our disclaimer